Drug intelligence / Profile preview

ibuprofen + pseudoephedrine

Development stage
Phase 1
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen + pseudoephedrine is an oral combination drug used for the temporary relief of symptoms associated with the common cold and flu, such as headache, fever, sinus pressure, nasal congestion, minor aches and pains. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis responsible for inflammation and pain. Pseudoephedrine is a sympathomimetic decongestant that stimulates alpha and beta adrenergic receptors to constrict blood vessels in nasal mucosa, reducing swelling and congestion. The combination provides more effective symptom relief than either agent alone[1][2][5].

Brand names
Advil Cold & SinusAdvil Cold and Sinus Liqui-GelDimetapp SinusDristan Sinus
Other names
ibuprofen/pseudoephedrine
02

Targets

ADRB1 (β1)ADRA1A (α1A)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ibuprofen + pseudoephedrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + pseudoephedrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call